Pieris Pharmaceuticals, which is developing a therapy for iron deficiency in anemic patients with chronic kidney disease, raised $25 million by offering 9.1 million shares at $2.75, below yesterday's closing price of $3.26 on the OTC Market. Pieris...read more
As many as 8 companies could go public in the US during the shortened holiday week. The week's three high-growth health care IPOs that are on the IPO calendar should receive the...read more
Things just got Seres in the IPO market. Thirteen companies went public this past week, more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its...read more
17 companies are on the calendar to go public this week and raise $2.5 billion. It should be the year's most active week in the IPO market; the second busiest week saw 10 IPOs in...read more
Pieris Pharmaceuticals prices IPO at $2.75
Pieris Pharmaceuticals, which is developing a therapy for iron deficiency in anemic patients with chronic kidney disease, raised $25 million by offering 9.1 million shares at $2.75, below yesterday's closing price of $3.26 on the OTC Market. Pieris...read more
Week ahead: Get ready for a dose of high-growth health care with 8 IPOs
As many as 8 companies could go public in the US during the shortened holiday week. The week's three high-growth health care IPOs that are on the IPO calendar should receive the...read more
US IPO Weekly Recap: Year's hottest deal pops 186% in year's most active week with 13 IPOs
Things just got Seres in the IPO market. Thirteen companies went public this past week, more than any week since October 2014. Seres Therapeutics skyrocketed 186% on its...read more
Week ahead: As many as 17 IPOs could price during the week of June 22
17 companies are on the calendar to go public this week and raise $2.5 billion. It should be the year's most active week in the IPO market; the second busiest week saw 10 IPOs in...read more